<?xml version="1.0" encoding="UTF-8"?>
<ref id="B21-vaccines-07-00091">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hashemi</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Pouyanfard</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Bandehpour</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Noroozbabaei</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Kazemi</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Saelens</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Mokhtari-Azad</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge</article-title>
  <source>PLoS ONE</source>
  <year>2012</year>
  <volume>7</volume>
  <elocation-id>e45765</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0045765</pub-id>
  <pub-id pub-id-type="pmid">23029232</pub-id>
 </element-citation>
</ref>
